Diroximel Fumarate

CAS 1577222-14-0 7 current recordsSmall Molecule

Who holds supplier records for Diroximel Fumarate? 7 organisations hold a current record for Diroximel Fumarate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (5), United Kingdom (1) and Netherlands (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Diroximel Fumarate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/diroximel-fumarate

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    5 of the 7 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Diroximel Fumarate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Diroximel Fumarate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Diroximel Fumarate is an oral medication used to treat relapsing forms of multiple sclerosis (MS) in adults. It is a prodrug that is rapidly converted into monomethyl fumarate, which exerts anti-inflammatory effects.

Chemical identity

IUPAC name
4-O-[2-(2,5-dioxopyrrolidin-1-yl)ethyl] 1-O-methyl (E)-but-2-enedioate
Canonical SMILES
COC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O
InChIKey
YIMYDTCOUQIDMT-SNAWJCMRSA-N
Synonyms
Vumerity API, alks-8700, alks8700, biib-098, biib098, rdc-5108, rdc5108, vumerity

Therapeutic areas

Multiple Sclerosis

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Diroximel Fumarate?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Diroximel Fumarate: ALIVUS LIFE SCIENCES LTD (India), Dr. Reddy's Laboratories Ltd. (India), HONOUR LAB LTD (India), Intas Pharmaceuticals Ltd. (India), Sterling Pharma Solutions Limited (United Kingdom), TAPI NL BV (Netherlands) and Zydus Lifesciences Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Diroximel Fumarate Drug Master Files are active?

ALIVUS LIFE SCIENCES LTD (DMF 35785), Dr. Reddy's Laboratories Ltd. (DMF 35793), HONOUR LAB LTD (DMF 36019), Intas Pharmaceuticals Ltd. (DMF 34677), Sterling Pharma Solutions Limited (DMF 32977), TAPI NL BV (DMF 33752) and Zydus Lifesciences Limited (DMF 35373). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Diroximel Fumarate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Diroximel Fumarate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.